DNA Damage as an Intermediate Biomarker in Intervention Studies

Experimental Biology and Medicine

Volumn 216, Issue 2, 1997, Pages 166-171

  Santella, Regina M ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BIPHENYLAMINE;

ARTICLE; CARCINOGENESIS; CYTOGENETICS; DNA ADDUCT; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CHEMOPREVENTION; CLINICAL TRIALS; DNA ADDUCTS; DNA DAMAGE; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030824592     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44166     Document Type: Article

References (51)

1. Hulka BS, Epidemiological studies using biological markers: Issues for epidemiologists. Cancer Epidemiol Biomarkers Prev 1:13-19, 1991.
2. Santella RM. DNA adducts in humans as biomarkers of exposure to environmental and occupational carcinogens. Environ Carcinog Rev C9:57-81, 1991.
3. P-postlabeling assay. Carcinogenesis 13:1053-1074, 1992.
4. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans. J Chromatog 580:293-323, 1992.
5. Hemminki K. DNA adducts in biomonitoring. J Occup Environ Med 37:44-51, 1995.
6. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE. Urinary aflatoxin biomarkers and risk of hepatocellular carcinogen. Lancet 339:943-946, 1992.
7. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3:3-10, 1994.
8. Wang LY, Hatch M, Chen CJ, Levin B, You SL, Lu SN, Wu MH, Wu WP, Wang LW, Wang Q, Huang GT, Yang PM, Lee HS, Santella RM. Aflatoxin exposure and the risk of hepatocellular carcinogen in Taiwan. Int J Cancer 67:620-625, 1996.
9. Lutz WK. Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens. J Cancer Res Clin Oncol 112:85-91, 1986.
10. Poirier MC, Beland FA. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: Implications for DNA adduct-based human cancer risk assessment. Chem Res Toxicol 5:749-755, 1992.
11. Greenwald P, Nixon DW, Malone WF, Kelloff GJ, Stern HR, Witkin KM. Concepts in cancer chemoprevemion research. Cancer 65:1483-1490, 1990.
12. Schatzkin A, Freedman LS, Dorgan J, McShane LM, Schiffman MH, Dawsey SM. Surrogate end points in cancer research: A critique. Cancer Epidemiol Biomarkers Prev 5:947-953, 1996.
13. Poirier MC. Antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA: Applications for detection of xenobiotics in biological samples. Mutat Res 288:31-38, 1993.
14. dell'Omo M, Lauwerys RR. Adducts to macromolecules in the bio- logical monitoring of workers exposed to polycyclic aromatic hydrocarbons. Crit Rev Toxicol 23:111-126, 1993.
15. Weston A. Physical methods for the detection of carcinogen-DNA adducts in humans. Mutat Res 288:19-29, 1993.
16. Kiyosawa H, Suko M, Okudaira H, Murata K, Miyamoto T, Chung M-H, Kasai H, Nishimura S. Cigarette smoking induces formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes. Free Radic Res Commun 11:23-27, 1990.
17. Takeuchi T, Nakajima M, Ohta Y, Mure K, Takeshita T, Morimoto K. Evaluation of 8-hydroxydeoxyguanosine, a typical oxidative DNA damage, in human leukocytes. Carcinogenesis 15:1519-1523, 1994.
18. Loft S, Vistisen K, Ewertz, M, Tjonneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: Influence of smoking, gender and body mass index. Cancer 13:2241-2247, 1992.
19. Inoue T, Mu Z, Sumikawa K, Adachi K, Okochi T. Effect of physical exercise on the content of 8-hydroxydeoxyguanosine in nuclear DNA prepared from human lymphocytes. Jpn J Cancer Res 84:720-725, 1993.
20. Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob RA, Ames BN. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci USA 88:11003-11006, 1991.
21. Lidnahl T. Instability and decay of the primary structure of DNA. Nature 362:709-715, 1993.
22. Verhagen H, Poulsen HE, Loft S, van Poppel G, Willems MI, van Bladeren PJ. Reduction of oxidative DNA-damage in humans by brussels sprouts. Carcinogenesis 16:969-970, 1995.
23. van Poppel G, Poulsen H, Loft S, Verhagen H. No influence of beta carotene on oxidative DNA damage in male smokers. J Natl Cancer Inst 87:310-311, 1995.
24. Duthie SJ, Ma A, Ross MA, Collin AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 56:1291-1295, 1996.
25. Green MHL, Lowe JE, Waugh APW, Aldridge KE, Cole J, Arlett CE. Effect of diet and vitamin C on DNA strand breakage in freshly-isolated human white blood cells. Mutat Res 316:91-102, 1994.
26. Hartmann A, Nieb AM, Grunert-Fuchs M, Poch B, Speit G. Vitamin E prevents exercise-induced DNA damage. Mutat Res 346:195-202, 1995.
27. Dyke GW, Craven JL, Hall R, Garner RC. Effect of vitamin C supplementation on gastric mucosal DNA. Carcinogenesis 15:291-295, 1994.
28. Prasad MPR, Mukundan MA, Krishnaswamy K. Micronuclei and carcinogen DNA adducts as intermediate end points in nutrient intervention trial of precancerous lesions in the oral cavity. Oral Oncol Eur J Center 318:155-159, 1995.
29. Gaziev AI, Sologub GR, Fomenko A, Zaichkina SI, Kosyakova NI, Bradbury RJ. Effect of vitamin-antioxidant micronutrients on the frequency of spontaneous and in vitro gamma-ray-induced micronulei in lymphocytes of donors: The age factor. Carcinogenesis 17:493-499, 1996.
30. Stich HF, Rosin MP, Homby AP, Mathew B, Sankaranarayanan R, Nair MK. Remission of oral leukoplakias and micronuclei in tobacco/ betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 42:195-199, 1988.
31. Stich HF, Hornby AP, Dunn BP. A pilot beta-carotene intervention trial with inuits using smokeless tobacco. Int J Cancer 36:321-327, 1985.
32. Stich HF, Rosin MP, Vallejera MO. Reduction with vitamin A and beta-carotene administration of proportion of micronucleated buccal mucosal cells in Asian betel nut and tobacco chewers. Lancet 1:1204-1206, 1984.
33. Santella RM, Lin CD, Cleveland WL, Weinstein IB. Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide. Carcinogenesis 5:373-377, 1984.
34. Poirier MC, Santella R, Weinstein IB, Grunberger D, Yuspa SH. Quantitation of benzo[a]pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res 40:412-416, 1980.
35. Santella RM, Gasparro FP, Hsieh LL. Quantitation of carcinogen-DNA adducts with monoclonal antibodies. Prog Exp Tumor Res 31:63-75, 1987.
36. Santella RM, Grinberg-Funes RA, Young TL, Dickey C, Singh VN, Wang LW, Perera FP. Cigarette smoking related polycyclic aromatic hydrocarbon-DNA adducts in peripheral mononuclear cells. Carcinogenesis 13:2041-2045, 1992.
37. Tang DL, Santella RM, Blackwood MA, Young TL, Mayer J, Tsai WY, Perera FP. A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol Biomarkers Prev 4:341-346, 1995.
38. Perera FP, Hemminki K, Young TL, Santella RM, Brenner D, Kelly G. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res 48:2288-2291, 1988.
39. Hemminki K, Grzybowska E, Chorazy M, Twardowska-Saucha K, Sroczynski JW, Putnam KL, Randerath K, Phillips DH, Hewer A, Santella RM, Young TL, Perera FP. DNA adducts in humans environmentally exposed to aromatic compounds in an industrial area of Poland. Carcinogenesis 11:1229-1231, 1990.
40. Santella RM, Hemminki K, Tang D, Paik M, Ottman R, Young TL, Savela K, Ludmilla V, Dickey C, Whyatt R, Perera FP. PAH-DNA adducts in while blood cells and urinary 1-hydroxypyrene in foundry workers. Cancer Epidemiol Biomarkers Prev 2:59-62, 1993.
41. Perera FP, Hemminki K, Grzybowska E, Motykiewiez G, Santella RM, Young TL, Dickey C, Brandt-Rauf P, DeVivo I, Blaner B, Tsai W, Chorazy M. Molecular damage from environmental pollution in Poland. Nature 360:256-258, 1992.
42. Grinberg-Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, Wang LW, Santella RM. PAH-DNA adducts in smokers and their relationship to micronutrient intake and serum levels and glutathione-S-transferase M1 genotype. Carcinogenesis 15:2449-2454, 1994.
43. d'Errico A, Taioli E, Chen X, Vineis P. Genetic metabolic polymorphisms and the risk of cancer: A review of the literature. Biomarkers 1:149-173, 1996.
44. Motykiewiez G, Malusecka E, Grzybowska E, Chorazy M, Zhang YJ, Perera FP, Santella RM. Immunohistochemical quamitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes. Cancer Res 55:1417-1422, 1995.
45. Zhang YJ, Hsu TM, Santella RM. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 4:133-138, 1995.
46. Hsu T-M, Zhang Y-J, Santella RM. Immunoperoxidase quantitation of 4-aminobiphenyl-and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 6:193-199, 1997.
47. Al-Atrash J, Zhang Y-J, Lin D, Kadlubar FF, Santella RM. Quantitative immunohistochemical analysis of 4-aminobiphenyl-DNA in cultured cells and mice: Comparison to gas chromatography/mass spectroscopy analysis. Chem Res Toxicol 8:747-752, 1995.
48. Curigliano G, Zhang Y-J, Wang L-Y, Flamini G, Alcini A, Ratio C, Giustacchini M, Alcini E, Cittadini A, Santella RM. Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers. Carcinogenesis 17:101-106, 1996.
49. Yin B, Whyatt RM, Perera FP, Randall MC. Jedrychowski W, Cooper Y, Santella RM. Determination of 8-hydroxydeoxyguanosine by immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic Biol Med 18:1023-1032, 1995.
50. 1 treated rat liver and human oral mucosal cells. Cancer Res 56:683-688, 1996.
51. Peterson K. "Natural" cancer prevention trial halted. Science 271:441, 1996.